SHA:603168 Revenue

Zhejiang Shapuaisi Pharmaceutical had revenue of 114.54M CNY in the quarter ending September 30, 2025, a decrease of -6.54%. This brings the company's revenue in the last twelve months to 475.19M, down -6.01% year-over-year. In the year 2024, Zhejiang Shapuaisi Pharmaceutical had annual revenue of 483.96M, down -24.96%.

Revenue (ttm)

475.19M

Revenue Growth

-6.01%

P/S Ratio

5.74

Revenue / Employee

357.82K

Employees

1,328

Market Cap

2.73B

Revenue Chart

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2024	483.96M	-161.01M	-24.96%
Dec 31, 2023	644.97M	95.43M	17.37%
Dec 31, 2022	549.54M	-80.23M	-12.74%
Dec 31, 2021	629.76M	282.96M	81.59%
Dec 31, 2020	346.81M	-169.15M	-32.78%
Dec 31, 2019	Pro	Pro	Pro
Dec 31, 2018	Pro	Pro	Pro
Dec 31, 2017	Pro	Pro	Pro
Dec 31, 2016	Pro	Pro	Pro
Dec 31, 2015	Pro	Pro	Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name	Revenue
Shaanxi Kanghui Pharmaceutical	513.23M
Chengdu huasun technology group Inc. , LTD.	658.28M
Hainan Huluwa Pharmaceutical Group	1.06B
Zhejiang Xinguang Pharmaceutical	257.07M
Enwei Pharmaceutical	888.64M
Anhui Huangshan Capsule	471.08M
Guhan Pharmaceutical Group	351.79M
Jilin Province Xidian Pharmaceutical Sci-Tech Development Co.,Ltd	252.77M

Revenue Rankings